Remove 2023 Remove Biotechnology Remove Mergers and acquisition activities
article thumbnail

JP Morgan Healthcare Conference 2025: Key Growth Opportunities Shaping the Future of Pharma and Biotechnology

Frost & Sullivan

Key Trends and Growth Opportunities Focus on Mergers & Acquisitions (M&A) Driving Industry Consolidation M&A activity emerged as a dominant theme at JPM 2025, with deals exceeding $18 billion announced during the conference. billion acquisition of Scorpion Therapeutics , adding a promising PI3K inhibitor program.